Lack of Efficacy Ends Trial Evaluating Janssen’s HIV Vaccine Candidate
The decision to discontinue the study was made based on an analysis from an independent data and safety monitoring board.
The decision to discontinue the study was made based on an analysis from an independent data and safety monitoring board.
The approval was based on a re-analysis of data from on observational study of Tdap vaccine effectiveness in the US.
The bivalent vaccine contains the original strain of the SARS-CoV-2 virus and a strain from the BA.4 and BA.5 lineages of the Omicron variant.
Immune responses after Priorix administration were noninferior to those observed with M-M-R II.
The new liquid formulation of Rotarix does not require reconstitution or dilution before use.
The RSVpreF vaccine candidate consists of 2 prefusion F proteins selected to optimize protection against RSV A and B.
The Menveo 1-vial presentation does not require reconstitution before use and is expected to be broadly available in mid-2023.
Effectiveness in preventing pertussis among infants younger than 2 months of age when administered during the third trimester of pregnancy was based on a reanalysis of data from an observational case-control study.
The quadrivalent modRNA influenza vaccine candidate uses mRNA technology, which requires only the genetic sequence of the virus.
In general, routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications and should be completed by the end of October.